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to undergo a spontaneous anti-Sm response. In these
mice, the prevalence is 25% and is independent of he-
reditary, maternal, and environmental factors (Eisenberg
et al., 1987b).
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anti-Sm response in MRL/lpr mice to understand the reg-Chapel Hill, North Carolina 27599
ulation of this response. Remarkably, we find that the²Department of Medicine
anti-Sm and anti-DNA responses overlap extensively;Section of Rheumatology
many anti-Sm hybridomas bind ssDNA and even dsDNAYale University School of Medicine
(Bloom et al., 1993a, 1993b). Anti-Sm antibodies areNew Haven, Connecticut 06520-8031
encoded by multiple VH and Vk gene segment combina-
tions and have noapparent restriction in VHCDR3 (Bloom
et al., 1993b), although in individual mice this responseSummary
is oligoclonal and involves somatic mutation (Bloom et
al., 1993a, 1993b; Retter et al., 1995). Although not re-Anti-Sm and anti-ssDNA transgenic (Tg) mice were
quired for specificity, somatic mutation can increasegenerated using the VH-D-JH rearrangement of an anti-
antibody affinity for Sm or DNA (Bloom et al., 1993a;Sm hybridoma of MRL/Mp-lpr/lpr origin. B cells of
Retter et al., 1996). These data rule out a requirementeach specificity account for 15%±35% of the splenic
for a rare V(D)J gene combination or somatic mutationrepertoire, but no circulating anti-Sm or anti-ssDNA
in controlling the prevalence of this response in MRL/antibodies are detected. Most autoreactive cells ex-
lpr mice and indicate that both Sm and DNA can drivehibit an immature B cell phenotype and have short
the anti-Sm response. The importance of this overlaphalf-lives equivalent to those of non-Tg immature B
to the development of autoimmunity has yet to be eluci-cells. However, at least some anti-Sm B cells are func-
dated.
tional, because immunization with murine snRNPs in- Anti-ssDNA-reactive B cells are generated in normal
duces anti-Sm secretion. We propose that anti-Sm mice and regulated peripherally. Anti-ssDNA antibodies
and anti-ssDNA are eliminated during the transition to and B cells are detected in normal mice (Pisetsky and
mature B cells and that this late stage of tolerance Caster, 1982; Conger et al., 1987), and immunization
induction is consequential to their spontaneous acti- with foreign DNA can induce an anti-ssDNA response
vation in murine lupus. (Diamond and Scharff, 1984; Gilkeson et al., 1989a,
1989b, 1990, 1991; Pisetsky et al., 1990; Messina et al.,
1991; Pisetsky, 1996; Ray et al., 1996). Moreover, anti-Introduction
DNA Tg mice directly demonstrate peripheral regulation
(Erikson et al, 1991; Offen et al., 1992; Tsao et al., 1993;
Patients with systemic lupus erythematosus (SLE), an
Roark et al., 1995). We speculate that anti-Sm B cells
autoimmune syndrome that predominantly afflicts wom- are similarly regulated and are present in the periphery
en, endure damage to various tissues including kidney because immunization with Sm or peptides of Sm can,
and heart (Alarcon-Segovia, 1988). SLE is characterized under certain circumstances, induce an anti-Sm re-
by the production of anti-nuclear antibodies, some of sponse in normal mice (Shores et al., 1988; Fatenejad
which may directly cause tissue damage (Alarcon-Sego- et al., 1993; Mamula et al., 1994; Bockenstedt et al.,
via, 1988; Shlomchik et al., 1994; Koren et al., 1995). 1995).
In particular, anti-Sm and anti-ssDNA antibodies are To elucidate the regulatory mechanisms governing
diagnostic of SLE; however, the prevalence of even anti-Sm B cells in normal mice, we have generated m
these specificities is less than 100%, because anti- chain transgenic mice using an unmutated, rearranged
ssDNA and anti-Sm are present in 70% and 25% of VHJ558 gene from the MRL/lpr anti-Sm hybridoma 2-12
SLE patients, respectively (Tan, 1989). The factors that (Bloom et al., 1993b; Retter et al., 1996). This VH is used
govern the prevalence of these responses are unknown. by clonally independent anti-Sm hybridomas from multi-
Our current understanding of responses to ssDNA and ple MRL/lpr mice and may be a common VH in this re-
Sm stems from analysis of mice of various inbred strains sponse (Bloom et al., 1993b). Antibodies composed of
that spontaneously develop an SLE-like disease (Cohen this H chain and other L chains can bind with varying
affinity to Sm, ssDNA, or both antigens (Retter et al.,and Eisenberg, 1982; Boyer et al., 1985; Shores et al.,
1995). In addition, some combinations bind neither anti-1986; Eisenberg et al., 1987a, 1987b, 1989, 1990; Shlom-
gen. Thus, 2-12H Tg mice are expected to generate Bchik et al., 1987, 1990; Marion et al., 1990; Tillman et
cells specific for Sm, ssDNA,or both amonga populational., 1992, Reap et al., 1993; Bloom et al., 1994; Fatenejad
of B cells that bind neither antigen and are presumablyet al., 1994; Radic and Weigert, 1994; Shan et al., 1994).
nonautoreactive.MRL/Mp-lpr/lpr (MRL/lpr) mice are the only mice known
We find that 2-12H chain Tg mice generate substantial
numbers of B cells specific for Sm and ssDNA. About³To whom correspondence should be addressed (e-mail: shl@med.
half of the splenic B cells, however, bind neither autoan-unc.edu).
tigen, allowing us to examine the regulation of specific§Present address: National Jewish Medical and Research Center,
Denver, Colorado 80206. autoreactive cells in the context of nonautoreactive cells
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Table 1. Serum IgM Levels From Tg and Non-Tg Mice
Tg Non-Tg
IgM (mg/ml) 1.4 6 0.789 3.9 6 2.87
IgMa (mg/ml) 0.377 6 0.196 ND
IgMb (mg/ml) 0.215 6 0.131 3.4 6 1.94
Data are from 10 Tg and 6 non-Tg mice.
ND, not detectable.
in the same mouse. Despite the presence of large num-
bers of autoreactive cells in the periphery, anti-Sm and
anti-ssDNA serum autoantibody is not detectable, al-
though in vitro lipopolysaccharide (LPS) stimulation of
these cells induces secretion of anti-Sm and anti-ssDNA
Figure 1. Tg Mice Do Not Have Elevated Levels of Anti-Sm or Anti-antibodies. Most anti-Sm- and anti-ssDNA-specific B
ssDNA Antibodiescells appear to be immature B cells, and many appear
Sera from Tg and non-Tg littermates were tested by ELISA for anti-to fail to progress beyond the immature phenotype, be-
Sm (S) and anti-ssDNA (D) antibodies as described in Experimentalcause the repertoires of the immature and mature sub-
Procedures. MRL/lpr serum was used as a positive control. Sera
sets differ substantially in the frequency of autoreactive from Tg and non-Tg littermates were diluted 1:500, whereas the
B cells. Surprisingly, immunization with mouse snRNPs MRL/lpr control sera was diluted 1:5000 for the anti-ssDNA ELISA
induces an anti-Sm response, indicating that at least and 1:500 for the anti-Sm ELISA. Limit of detection was 0.75 mg/ml
IgM for anti-Sm and anti-ssDNA.some anti-Sm B cells are functional. We propose a
model of peripheral regulation in which many B cells of
both specificities fail to become long-lived mature B
4). Sm-binding cells stain with variable intensities indi-cells.
cating that they exhibit a range of affinities for Sm, al-
though there appear to be discreet subpopulations, the
Results largest of which stains approximately 20-fold brighter
than non-Sm binding, IgM1 B cells (Figure 2). ssDNA
The 2-12H Transgene Supports B binding appears to be less variable in intensity. Because
Cell Development the H chain is constant, these differences in binding
The 2-12H transgene construct used to generate the Tg intensity must be due to the use of different L chains.
mice (Retter et al., 1995) consists of the 2-12H V(D)J The percentage of cells in non-Tg littermates that stain
cloned upstream of the Igha allotype Cm exons. The with either of these reagents is at least 4-fold lower.
transgene encoded H chain excludes endogenous gene Analysis of hybridomas from 2-12H Tg mice is underway
rearrangement and supports B cell development. Immu- to determine the percentage of B cells that bind Sm and
nofluorescence analysis of spleen cells with anti-IgMa ssDNA, but preliminary data indicate that fewer than
and anti-IgMb reveals that approximately 92% of the B 10% of anti-Sm B cells bind ssDNA. Thus, it appears
cells in Tg mice express the transgene H chain and that that about half or more of the splenic B cells in 2-12H
the remainder express an endogenous H chain (data not
shown). Approximately 3% stain for both allotypes, as
compared to 0.35% of control B cells (data not shown).
The level of serum IgMa is approximately 10-fold lower
than IgM of non-Tg mice but almost 2-fold higher than
that of endogenous IgMb (Table 1). Thus, Tg-expressing
B cells can differentiate to antibody-secreting cells.
However, the level of circulating anti-Sm and anti-ssDNA
as determined by ELISA is indistinguishable from that
of non-Tg littermates (Figure 1).
Anti-Sm and Anti-ssDNA B Cells Populate
the Spleen
Based on our earlier L chain pairing analysis (Retter et
al., 1995), we expected 2-12H Tg mice to generate anti-
Sm, anti-ssDNA, anti-Sm/ssDNA, and non-Sm, non±
Figure 2. 2-12H Tg Mice Have Large Numbers of Splenic Anti-SmssDNA binding B cells. The latter, we presume, are non-
and Anti-ssDNA B Cellsautoreactive. To determine whether autoreactive cells
Spleen cells were prepared from Tg (top) and non-Tg (bottom) miceare made and reach the periphery, three-color immuno-
and costained with IgMa-PE or IgMb-PE, respectively, anti-B220-fluorescence of spleen cells with anti-B220, anti-IgMa,
CyChrome and either biotinylated Sm (left) or DNA (right) followed
and either biotinylated Sm or ssDNA was performed. by streptavidin-FITC. Histograms are gated on B2201 cells. Percent-
The percentage of IgM1 cells that stain with Sm or ages are of B2201 cells. Data shown are representative of at least
10 mice analyzed.ssDNA ranges from 15%±35% (Figure 2; see also Figure
Regulation of Anti-Sm and Anti-DNA B Cells
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Table 2. Analysis of Hybridomas Generated from 2-12H Tg Mice
Fusion Fusion Partner Screened Anti-Sm Anti-ssDNA Non-Sm, Non-ssDNA
1 Ag8.653 51 1 (2%) 0 50 (98%)
2 Ag8.653 90 5 (5.5%) 1 (1.1%) 84 (93%)
3 NSO/1-bcl-2 672 168 (25%) 235 (35%) 269 (40%)
4 NSO/1-bcl-2 982 359 (36%) 377 (38%) 246 (25%)
Tg mice are autoreactive. The Sm and ssDNA-binding IgMhi phenotype (Allman et al., 1992, 1993) (Figures 3A
and 3B), thereby eliminating the level of surface IgM asreceptors cocap with IgM (data not shown), demonstra-
ting that binding of Sm and DNA is mediated by IgM a variable. We observe that the frequencies of anti-Sm
and anti-ssDNA B cells are 35% and 18%, respectively,rather than by a non-Ig molecule, as has been described
for DNA (Bennett et al., 1987; Loke et al., 1989; Yakubov comparable to those of adult splenic B cells (Figure 3B).
Thus, one-half to two-thirds of the B cells in 2-12H Tget al., 1989; Hefeneider et al., 1992a, 1992b; 1993; Krieg
et al., 1995). mice are autoreactive, and one-third to one-half do not
bind Sm or DNA and are presumably nonautoreactive.Figure 2 also shows that the surface IgM (sIgM) level
on autoreactive B cells is approximately 10-fold higher
than that on non-Sm, non±ssDNA staining B cells. The The Majority of Autoreactive B Cells Are Immature
To identify the differentiative stage of anti-Sm and anti-sIgM on non-Sm, non±ssDNA binding B cells is not dif-
ferent from that on non-Tg B cells (data not shown). ssDNA B cells in adult mice, we examined these cells
for heat-stable antigen (HSA or CD24) and CD23 expres-This is in contrast to the receptor down-regulation char-
acteristic of tolerant B cells in hen egg lysozyme (HEL) sion, two markers that discriminate between immature
and mature follicular B cells. HSA is expressed at highTg mice (Goodnow, et al., 1989) but similar to the IgMhi
phenotype of anti-ssDNA B cells of 3H9 Tg mice de- levels by immature B cells but at low levels by mature
B cells (Allman et al., 1992, 1993), whereas CD23 isscribed by Erikson et al. (1991). To exclude the possibil-
ity that IgMlo B cells may bind Sm or ssDNA in these expressed only by mature B cells (Carsetti et al., 1995).
2-12H Tg mice have slightly elevated numbers of HSAhi,mice yet escape detection because the level of surface
Ig is too low for detectable staining, we generated a immature B cells relative to non-Tg littermates (Figure
4A). Three-color immunofluorescence indicates that thelarge number of hybridomas from Tg spleen cells and
determined the frequency of anti-Sm, anti-ssDNA, and majority of autoreactive B2201 B cells in these Tg mice
are HSAhi and CD232 (Figures 4B and 4C), consistentnon-Sm, non±ssDNA binding hybridomas (Table 2).
Only two of the four fusions performed generated appre- with an immature B cell. Essentially all of the HSAhi B
cells bind either Sm or ssDNA. About one fourth of theciable numbers of anti-Sm and anti-ssDNA hybridomas.
Among the hybridomas of these two, 25%±36% secrete anti-Sm and anti-ssDNA B cells are HSAlo and CD232,
suggesting that some autoreactive B cells have a matureanti-Sm antibodies, 36%±38% secrete anti-ssDNA anti-
bodies, and 25%±40% secrete antibodies that bind nei- B cell phenotype, although the majority of HSAlo B cells
appear to be nonautoreactive. All anti-Sm and anti-ther autoantigen (Table 2). The lack of reactivity to Sm
or ssDNA by some hybridomas of the latter group was ssDNA B cells are CD432 (Figure 4), ruling out assign-
ment to the B-1 cell subset. Anti-Sm and anti-ssDNA Bverified by subcloning and assaying at high IgM concen-
trations (800 mg/ml). These frequencies of anti-Sm and cells are also CD221, Pgp-11, Faslo/2, and CD191 (data
not shown).anti-ssDNA are very similar to those determined by flow
cytometry (Figure 2), verifying that a large fraction of The high IgM and HSA levels of anti-Sm and anti-
ssDNA B cells are also characteristic of marginal zonethe B cells in these mice do not bind either autoantigen.
Thus, it is unlikely that a significant number of anti-Sm B cells. Marginal zone B cells are mature, noncycling,
noncirculating, and long-lived B cells that appear to beor anti-ssDNA B cells are not detected by flow cytome-
try. Both the totalnumber of hybridomas and the number involved prominently in T-independent type 2 responses
(Snapper et al., 1993). They may also be antigen-of autoreactive hybridomas are significantly elevated
using a fusion partner that expresses a transfected bcl-2 selected (Chen et al., 1997). Expression of CD21 is com-
monly used to distinguish immature and marginal zonegene (NSObcl-2) relative to a standard fusion partner
(Table 2). Although we are not certain why the fusion B cells (Cyster and Goodnow, 1995); however, Sm and
ssDNA interfere with the binding of anti-CD21. There-efficiency is increased, it is possible that an intrinsic
property of the anti-Sm and anti-ssDNA B cells permits fore, we could not directly determine CD21 expression
levels by autoreactive B cells. However, the percentagefusion and survival with a bcl-2-transfected fusion part-
ner more so than with the bcl-22 fusion partner. The of CD21hi, B2201 marginal zone B cells is roughly 11%
in Tg and 9% in non-Tg mice (data not shown). There-improved fusion efficiency with NSObcl-2 may be attrib-
utable to tolerance induction (see below) as previously fore, the size of the marginal zone B cell population in
these mice is unaltered by Tg expression and is insuffi-suggested by Ray and Diamond (1994).
As a second confirmation of the frequencies of anti- cient to account for the autoreactive B cell populations
in these mice.Sm, anti-ssDNA, and non-Sm, non±DNA binding B cells
in the 2-12H Tg repertoire, we examined the splenic B Immature follicular B cells differ significantly in half-
life from both mature follicular and marginal zone B cells.cells of 24-day-old mice. At this age, nearly all splenic
B cells are immature B cells, as indicated by the HSAhi, Immature B cells have a half-life of less than a week,
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time at which 50% of the cells are labeled, for HSAhi B
cells of both Tg and non-Tg mice is approximately 1
week. Because essentially all of the HSAhi B cells are
autoreactive (Figure 4B), these data indicate that the
majority of autoreactive B cells have the short half-life
of an immature B cell, not mature follicular or marginal
zone B cells. Thus, we conclude that anti-Sm and anti-
ssDNA B cells of 2-12H Tg mice are immature follicular
B cells. Tg HSAlo B cells appear to have a slightly lower
half-life compared to non-Tg mice. The significance of
this is unknown, but one possible explanation is that
the autoreactive HSAlo B cells have shorter half-lives
than nonautoreactive HSAlo B cells.
Assignment to the immature subset of B cells predicts
that these cells will constitute a high percentage of B
cells in the bone marrow. As shown inFigure 3C, approx-
imately 16% of IgM1 cells in adult bone marrow bind
Sm, and approximately 9% bind ssDNA. Although this
is a somewhat smaller proportion than observed in the
spleen, these data indicate that a large percentage of
newly generated B cells bind one or the other autoanti-
gen, thereby excluding accumulation or clonal expan-
sion of these cells as the explanation for the high propor-
tion of autoreactive B cells in the spleen, as reported
for marginal zone B cells and B-1 cells (Arnold et al.,
1994; Chen et al., 1997).
The anti-Sm and anti-ssDNA B cells do not migrate
out of the spleen in significant numbers. As shown in
Table 3, lymph nodes of Tg and non-Tg mice are not
appreciably different in the percentage of anti-ssDNA B
cells, and Tg mice have only a slightly higher frequency
of anti-Sm B cells than non-Tg mice. No differences
between Tg and non-Tg mice are apparent among peri-
toneal cells.
Anti-Sm Secretion In Vitro and In Vivo
To assess whether anti-Sm and anti-ssDNA B cells can
beactivated to secreteanti-Sm and anti-ssDNA antibod-
ies, we LPS-stimulated splenocytes for 3 days and mea-
sured the Smand ssDNA-binding activityof thesecretedFigure 3. Anti-Sm and Anti-ssDNA B Cells from 24-Day-Old Mice
antibody. LPS stimulation resulted in secretion of anti-(A) Two-color immunofluorescence was performed using spleen
cells from non-Tg (left), 24-day-old Tg (middle), and adult Tg (right) Sm antibodies from Tg but not non-Tg mice (Figure 5).
mice. Staining was done with B220-CyChrome and HSA-PE. Data Anti-ssDNA antibodies were low even in Tg cell cultures,
shown are representative of approximately 16 mice analyzed. suggesting they are less responsive to LPS than anti-
(B) Spleen cells from 24-day-old Tg mice were stained with IgMa,
Sm B cells.B220 and either Sm or ssDNA. Histograms are gated on B2201 cells
To test the responsiveness of the anti-Sm B cellsand percentage of autoantigen-binding B cells is given. Data are
in vivo, Tg mice were immunized once with murinerepresentative of 16 mice analyzed.
(C) Anti-Sm and anti-ssDNA B cells are present in the bone marrow snRNPs, and anti-Sm reactivity was assayed 10 days
of 2-12H Tg mice. Gates were set on B2201, IgM1 populations and later. Figure 6 and Table 4 show that anti-Sm levels
analyzed for Sm and ssDNA binding. Data shown are representative are significantly elevated above the preimmune anti-Sm
of three experiments using three mice each.
titers. Adjuvant alone did not increase the level (Table
4), and there was no increase in anti-ssDNA levels in
these mice (Figure 6, Table 4), arguing that the responsewhereas the latter B cells have long half-lives of 4 or
is Sm-specific and driven by the snRNP immunogenmore weeks (FoÈ rster and Rajewsky, 1990; Allman et al.,
rather than the result of polyclonal activation.1993, Chen et al., 1997). To determine whether the half-
lives of the autoreactive B cells in 2-12H Tg mice are
characteristic of immature or matureB cells, we followed Discussion
the incorporation of BrdU by HSAhi and HSAlo B cells.
Analysis of BrdU incorporation by HSAhi B cells shows We have demonstrated that 2-12H Tg mice have large
numbers of splenic anti-Sm and anti-ssDNA B cells,that Tg and non-Tg HSAhi B cells incorporate BrdU at
equivalent rates, indicating that these B cells are replen- each accounting for 15%±35% of the repertoire. The
majority of these cells are immature follicular B cellsished at the same rates (Figure 4C). The half-life, the
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Figure 4. Anti-Sm and Anti-ssDNA B Cells in the Spleens of Adult 2-12H Tg Mice Have an Immature Phenotype
(A) The proportion of B cells that are HSAhi is slightly higher in Tg mice than in non-Tg littermates. Immunofluorescence was performed on
spleen cells from Tg and non-Tg littermate mice using B220-CyChrome and HSA-PE. Percentages of B cells that are either HSAhi or HSAlo
are given. Data shown are representative of approximately 14 mice analyzed.
(B) Anti-Sm and anti-ssDNA B cells from Tg (top) and non-Tg (bottom) mice were analyzed by three-color immunofluorescence as described
in Figure 2. Histograms are gated on B2201 cells.
(C) Phenotypic analysis of splenocytes gated on B2201 and either Sm1, ssDNA1, or all B cells. Tg splenocytes are presented in the top three
rows and non-Tg splenocytes in the bottom row. Immunofluorescence data are representative of three to five experiments using four 3-month-
old mice each. Staining was done as described in Figure 2.
(D) BrdU incorporation into HSAhi (left) and HSAlo (right) B cell populations in Tg (thick line) and non-Tg (thin line) mice was performed as
described in Experimental Procedures. Dotted lines indicate the time at which 50% of the B cells were labeled. For each time point, two Tg
and two non-Tg mice were used; labeling was begun on mice at approximately 2 months of age.
that are short-lived and have an IgMhi, HSAhi, CD432, the cells are essentially newly generated immature B
cells, and adult bone marrow, we estimate that a compa-and CD232 phenotype, indistinguishable from immature
follicular B cells of non-Tg mice. About one fourth of rable frequency of newly generated B cells are anti-Sm
and anti-ssDNA. We presume that this is due to a largethe autoreactive B cells have a mature B cell phenotype
and are IgMlo, HSAlo, CD231, and CD432. Based on anal- number of L chains that can contribute to the binding
to one or the other autoantigen when combined to theysis of spleen cells from 24-day-old mice, where all of
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Table 3. Percentage of Peripheral Anti-Sm and Anti-ssDNA B Cells among B2201 Cells in Lymph Node and Peritoneum
Lymph Node Peritoneum
Tg SM (%) DNA (%) SM (%) DNA (%)
Experiment 1 1 ND 5.5 ND ND
1 ND 7.0 ND 12.3
2 ND 5.2 ND 6.4
Experiment 2 1 4.6 7.2 1.1 1.7
1 5.2 4.8 1.8 4.0
2 1.7 5.5 ,1 6.1
Experiment 3 1 3.9 2.7 ,1 2.2
1 2.8 4.2 3.4 2.0
2 1.8 2.4 ,1 3.6
ND, not done.
2-12H chain, because we have previously determined This analysis does not address whether some anti-
that multiple diverse L chains can pair in vitro with the Sm and anti-ssDNA B cells expressing the 2-12H
2-12H chain and bind Sm or ssDNA or both (Retter et transgene are deleted in the bone marrow. In this model,
al., 1995). Thus, these dataargue that thehigh frequency the affinity of antibody for Sm or ssDNA is dependent
of these cells in the adult spleen is not due to accumula- on the associated L chain. Cells that produce an L chain
tion or clonal expansion of autoreactive B cells but due that confers a high affinity for either autoantigen may
to their frequent generation. be centrally deleted upon expression of the IgM recep-
Despite the large number of autoreactive B cells, the tor, as is the case for high affinity anti-DNA B cells (Chen
levels of anti-Sm and anti-ssDNA in circulation are not et al., 1994, 1995).
different from those of non-Tg littermates. Therefore, How anti-Sm and anti-ssDNA B cells are regulated is
these cells are not spontaneously activated in normal uncertain. One possibility is that these cells are simply
mice, arguing that they are regulated peripherally. Pe- not activated in nonautoimmune mice due to a low affin-
ripheral regulation of anti-ssDNA B cells has been pre- ity for autoantigen, to insufficient levels of endogenous
viously demonstrated (Erikson et al., 1991; Offen et al., antigen, or to a lack of appropriate T cell help. However,
1992; Tsao et al., 1993; Roark et al., 1995), and the our data suggest a more active process of B cell regula-
presence of anti-Sm B cells in the periphery is predicted tion. We propose that anti-Sm and anti-ssDNA B cells
from immunization experiments of normal mice with for- are eliminated from the periphery during the transition
eign molecular mimics and peptides of Sm (Fatenejad to a mature B cell. This possibility is based on the finding
et al., 1993; Mamula et al., 1994; Bockenstedt et al., that the frequency of autoreactive B cells in the mature
1995). The presence of anti-Sm and anti-ssDNA B cells B cell subset is less than that in the immature B cell
in the periphery is physiologically relevant, because B subset (Figure 7). Essentially, the entire immature reper-
cells expressing the 2-12 VH incombination with different toire in adult 2-12H Tg spleens is autoreactive; over 40%
VL are likely to be generated in normal mice; the Tg
encodes an unmutated H chain, and the L chains with
which it associates should also be unmutated. Thus, the
2-12H Tg mouse is a model of peripheral tolerance to
both DNA and protein autoantigens.
Figure 5. Tg Spleen Cells Can Be Induced In Vitro to Produce Auto-
antibodies by Activation with LPS Figure 6. Immunization of Tg Mice with snRNPs Induces Anti-Sm
Antibody ProductionSpleen cells from Tg (filled circles) or non-Tg (open circles) mice
were cultured for 72 hr in the presence and absence of 50 mg/ml Tg mice were immunized intraperitoneally with snRNPs in CFA. After
10 days serum was drawn, and anti-Sm (A) and anti-ssDNA (B)LPS. Supernatants were harvested and quantitated for IgM (left) and
anti-Sm and anti-DNA (right) production using ELISA as described reactivity was measured. Data is presented for individual mice be-
fore (white bars) and after (black bars) immunization. In the absencein Experimental Procedures. Anti-Sm and anti-ssDNA reactivity was
undetectable in cultures from non-Tg mice in the absence of LPS. of snRNPs, no serum anti-Sm is detected, as with unimmunized
mice.Data are presented in mg/ml.
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whereas immature and mature B cells are not, sug-Table 4. Anti-Sm Levels in snRNP Immunized 2-12H Tg Mice
gesting that these cells are normally targeted for nega-
Sera (mg/ml) Level
tive selection in vivo. Bone marrow transitional cells
Preimmune ND have an approximately 10-fold higher level of surface
CFA ND IgM than immature and mature cells, and they appear
snRNP 1 CFA 5.15 6 2.15
to be equivalent to the HSAhi B cells of the spleen (Allman
Data from 5 mice. et al., 1993; Carsetti et al., 1995). Thus, anti-Sm and
ND, not detectable. The limit of detection is 0.75 mg/ml. anti-ssDNA B cells in 2-12H Tg mice appear to reach
the deletion-sensitive transitional stage of development.
High sIgM levels are also seen in 3H9 H chain Tg and
3H9/Vk8 double Tg mice (Erikson et al., 1991). Theseof splenic B cells are immature as defined by the HSAhi
mice express an H chain that confers specificity for DNA,phenotype, and the percentage of HSAhi, anti-Sm and
and like 2-12H Tg anti-ssDNA Bcells, 3H9Tg anti-ssDNAanti-ssDNA B cells is also over 40% (Figure 4). Using
B cells do not spontaneously secrete antibody. Recentflow cytometry, only about one fourth of the mature B
analysis of these mice indicates that the anti-ssDNAcell subset is autoreactive (Figure 4); the remainder are
B cells are also immature (Mandik-Nayak et al., 1997),non-Sm, non±ssDNA binding B cells. Although some
suggesting that developmental arrest occurs at theautoreactive B cells may not be detected by flow cytom-
transition from immature to mature B cells as in theetry because of their low surface IgM level, the number
2-12H Tg.of undetected autoreactive B cells is likely to be low
At least some anti-Sm B cells appear to be functionalbased on the hybridoma analysis (Table 2) and on analy-
in these mice, because immunization with murine snRNPssis of B cells from 24-day-old spleens (Figure 3). Thus,
induces an anti-Sm response. This is consistent withthe immature and mature B cell repertoires are not
the lack of sIgM down-regulation among immature anti-equivalent. Deletion of autoreactive B cells from the
Sm and anti-ssDNA B cells. This is the first demonstra-mature repertoire could account for the lower half-life
tion of anti-Sm B cell activation in vivo by murineof HSAlo B cells in 2-12H Tg mice (Figure 4). Which cells
snRNPs, possibly because 2-12H Tg mice have a higherbecome mature is likely to be dependent on affinity for
frequency of these cells relative to non-Tg mice (Fatene-autoantigen, with the highest affinity being excluded
jad et al., 1993; Mamula et al., 1994; Bockenstedt et al.,from the mature B cell repertoire. We are currently test-
1995). This is not a nonspecific activation because anti-ing this prediction.
ssDNA antibody levels are not altered by this immuniza-A loss of anti-Sm and anti-ssDNA B cells during the
tion. Whether all anti-Sm B cells are functional is un-transition to the mature B cell subset would be consis-
known. Possibly, only the mature HSAlo B cells that aretent with findings that immature cells are sensitive to
Smdull (Figure 5) are responsible for the observed re-deletion by soluble antigen (Stashenko and Klinman,
sponse, although immature B cells can respond to anti-1980; Klinman et al., 1981; Nossal, 1983; Riley and Klin-
gen if provided T cell help (Chang et al., 1991; Allmanman, 1986; Carsetti et al. 1995). The phenotype of the
et al., 1992, 1993). T cells in these mice proliferate indeletion-sensitive immature B cell has been further ex-
response to peptides of the D protein component of Smplored by Carsetti et al. (1995). They define a transitional
in vitro (M. J. M., unpublished data), suggesting thatB cell in thebone marrow that is intermediate in develop-
functional anti-Sm T cells are available for B cell activa-ment to immature and mature B cells. Transitional cells
tion. The reason that unimmunized 2-12H Tg mice doare sensitive to deletion by surface IgM cross-linking,
not undergo a spontaneous anti-Sm response despite
the presence of functional Sm-specific B and T cells
may be due to the concentration, form, or accessibility
of antigen. Regardless, the anti-Sm B and T cell data
together suggest the intriguing possibility that tolerance
to Sm is achieved through regulation of the B cell, not
the T cell.
We cannot completely exclude the possibility that
anti-Sm B cells are anergic, despite the fact that many
are IgMhi and that these mice are responsive to snRNP
immunization. The immunization with snRNPs may have
provided a form of SmD that is able to overcome anergy,
similar to the way in which membrane-bound HEL can
overcome anergy of anti-HEL B cells (Cooke et al., 1994).
Alternatively, only some anti-Sm B cells may be anergic
Figure 7. The Immature and Mature B Cell Repertoire of 2-12H Tg (e.g., those that show a mature phenotype). These may
Mice Differ in the Proportion of Autoreactive B Cells preferentially be those that have a high affinity. Thus,
In 2-12H Tg mice, the peripheral repertoire of mature B cells differs anergy may still play a role in the regulation of anti-Sm
from immature in that the mostof the autoreactive B cell populations B cells. Anergy has been demonstrated to play a role
are present in lymphoid organs harboring immature B cells. Shown
in anti-DNA B cell regulation in 3H9 Tg mice (Erikson etabove is the distribution of immature, mature, autoreactive, and
al., 1991; Mandik-Nayak et al. 1997). Whether the anti-nonautoreactive B cells in lymph node (LN) and spleen. Percentage
ssDNA B cells of 2-12H Tg mice are functional or anergicof B cells in each population is represented along the Y axis. Graph
represents data compiled from Figure 4B. has not yet been determined. However, anti-ssDNA B
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cells secrete little antibody relative to anti-Sm B cells These results demonstrate a peripheral tolerance
after LPS stimulation in vitro, suggesting that the former mechanism acting on anti-Sm and anti-ssDNA B cells.
are anergic like their counterparts in 3H9 Tg mice (Erik- Anti-Sm B cells of three clones using this H chain in
son et al., 1991; Mandik-Nayak et al. 1997). association with different L chains were activated in
It is interesting that, although both anti-Sm and aner- separate MRL/lpr mice undergoing an anti-Sm response
gic anti-HEL B cells enter the periphery, they differ in the (Bloom et al., 1993b). Therefore, the defect in the regula-
expression level of sIgM and responsiveness to antigen tion of anti-Sm and anti-ssDNA B cells in MRL/lpr mice
(Goodnow et al., 1989, 1991; Adams et al., 1990; Cooke likely involves overcoming peripheral tolerance. Be-
et al., 1994). Unlike anti-Sm B cells, anergic anti-HEL B cause at least anti-Sm B cells are not anergic, they may
cells have a 20-fold lower level of sIgM than nonautore- be especially susceptible to inappropriate activation.
active cells and are unresponsive to antigen due to an Indeed, 2-12H Tg mice on an MRL/lpr background spon-
uncoupling of the IgM receptor complex from the normal taneously produce high titers of anti-Sm and anti-ssDNA
signal transduction pathway (Bell and Goodnow, 1994; beginning before 1 month of age (S. Ferguson and
Cooke et al., 1994; Eris et al., 1994). These differences S. H. C., unpublished data), supporting the conclusion
are probably related to the strength of the tolerogenic that MRL/lpr mice are defective in this mechanism of
signal received by the B cell. Tg anti-HEL B cells have peripheral regulation (Rathmell and Goodnow, 1994;
an extraordinary affinity for HEL, and in Tg mice also Rubio et al., 1996). This is consistent with the observa-
producing soluble HEL, these cells are exposed to high tions of others that central tolerance is intact in MRL/
levels of tolerogen, a combination that probably results lpr mice (Rathmell and Goodnow, 1994; Rubio et al.,
in a decrease in sIgM levels and loss of signaling func- 1996).
tion. This is supported by the observation that anti-HEL
B cells exposed to a lower level of soluble HEL exhibit Experimental Procedures
a smaller modulation of sIgM (Goodnow et al., 1989;
MiceFulcher et al., 1996). Anti-Sm and anti-ssDNA B cells of
Tg mice were generated using the rearranged V(D)J segment of2-12H Tg mice are unmutated and may be of low affinity
hybridoma 2-12H (Bloom et al., 1993b) cloned upstream of the Igha(Retter et al., 1996), and the level of available Sm and
Cm gene (Retter et al., 1995). Purified insert was injected intossDNA may be low. Thus, the degree of anti-Sm receptor
(C57BL/6 3 SJL)F1 blastocysts andthen implanted intopseudopreg-engagement in 2-12H Tg mice may be below that neces- nant mice. Two Tg founders were obtained and further backcrossed
sary to induce receptor down-regulation on newly gen- to C57BL/6 or C.B17 mice for eight or more generations. Transmis-
erated immature B cells. sion of the transgene was verified by polymerase chain reaction
analysis of tail DNA using an oligonucleotide identical to a sequenceAn interesting parallel can be drawn between the
470 bp 59 of the 2-12 VH exon (59-CAGACTAAGGCCAAATATCAACT2-12H chain Tg mice and anti-HEL H chain-only Tg mice
GAGAGA-39) and an oligonucleotide complementary to a sequencein which multiple L chains are available for pairing with
39 of JH4 (59-CAGGCTCCACCAGACCTCTCTAGA-39) (Retter et al.,transgene-encoded H chains (Cyster et al., 1994; Hartley
1996). DNA was prepared by incubating tail snips in 50 mM Tris-
and Goodnow, 1994). Anti-HEL H chain±only Tg mice HCl (pH 8.0), 100 mM EDTA, 100 mM NaCl, and 1% SDS (modified
have few splenic anti-HEL B cells, and those generated STE) buffer (Drews et al., 1994) with 1 mg/ml proteinase K at 558C
appear to be of low affinity. The anti-HEL B cells fall overnight. For amplification 2 ml of tail digest was added to 50 ml
of polymerase chain reaction mix consisting of 1.25 mM dNTP's,into discreet subsets depending on the affinity of their
1.5 mM MgCl2, each primer at 2 mM, 5 U Taq polymerase (Promega,sIgM and HEL staining intensity. In the presence of low
Madison, WI), and 5 ml of 103 polymerase buffer (Promega). Reac-levels of soluble HEL, B cells of the higher affinity sub-
tions are run for 30 cycles at 948C for 1 min, 558C for 2 min, andsets are deleted, while lower affinity subsets remain.
728C for 3 min, followed by 10 min at 728C for 1 cycle in a Perkin-
With increasing concentrations of HEL, these lower af- Elmer/Cetus thermocycler. Several founder lines (C57BL/6 3 CB.17)
finity sets of B cells are also lost. Some of the remaining F2 were generated, and one is presented here in detail. Animals
anti-HEL B cells are IgMhi, raising the possibility that are age- and sex-matched in all experiments and are housed in a
conventional facility at UNC.they are immature. Whether these cells are functional
is not known. These data support the idea that the anti-
Serum ELISASm and anti-ssDNA B cells in 2-12H Tg mice have not
Detection of anti-DNA and anti-Sm by ELISA was done as previously
received a signal of sufficient strength to induce down- described (Eisenberg et al., 1982; Bloom et al., 1993b). Briefly, 96-
regulation of sIgM, a characteristic of tolerant high-affin- well PVC plates were coated with antigen in borate-buffered saline
ity anti-HEL B cells. (BBS) (Mishell and Shiigi, 1980), washed, and blocked with BBS/
We propose, therefore, that contact with Sm, if it oc- BSA/Tween(BBT). All washes were done with BBS. Mouse sera were
serially diluted in BBT then added to antigen coated plates in dupli-curs in the bone marrow, is not sufficiently strong to
cate. IgM was quantitated by adding sera to plates coated withalter normal development through the transitional cell
polyclonal goat anti-mouse IgM (Southern Biotechnology, Bir-stage, and that up until this stage these cells are func-
mingham, AL) and detected with either biotinylated anti-IgMa
tional and responsive to antigen and T cell help. How- (HB100) F(ab)2 fragments (a kind gift from P. Cohen) or intact anti-
ever, as transitional cells in the spleen, they are subject IgMa or anti-IgMb (Pharmingen, San Diego, CA), followed by strepta-
to deletion or anergy because the high sIgM level medi- vidin-alkaline phosphatase (Southern Biotechnology). Assays were
developed with 1 mg/ml p-nitrophenyl phosphate (Sigma, St. Louis,ates a stronger negative signal, and they are more sensi-
MI) in 0.01 M diethanolamine and the OD405 determined. Serum titerstive to IgM cross-linking-induced cell death than imma-
of IgM were determined by generating a standard curve from serialture B cells (Carsetti et al., 1993, 1995; Norvell et al.,
dilutions of TEPC 183 (IgMa) or CBPC17 (IgMb) in each assay.
1995; Monroe, 1996; Norvell and Monroe, 1996). Thus,
the combination of low-affinity and low-antigen concen- LPS Stimulation
tration may not permit tolerance induction until a stage Spleen cells were harvested aseptically, washed, and resuspended
at 1 3 106 cells/ml in complete DMEM-H and incubated for 72 hr inlate in differentiation at the transition to a mature B cell.
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10% CO2 in the presence or absence of 50 mg/ml LPS. Supernatants quantitated by ELISA for IgMa production and then tested for anti-
ssDNA and anti-Sm reactivity as described above.from triplicate cultures were tested by ELISA for anti-Sm, anti-
ssDNA, and IgM production.
Immunizations
Immunofluorescence Mice were immunized intraperitoneally with 100 mg murine snRNPs
Bone marrow was extracted from femurs of the two hind legs. in complete Freunds adjuvant (CFA) (Sigma) or CFA alone as de-
Spleens and lymph nodes were collected and made into single-cell scribed previously (Fatenejad et al., 1993; Mamula et al., 1994; Bock-
suspensions by crushing between the frosted ends of glass slides. enstedt et al., 1995). Serum was collected before and at 10 days
Cells from the peritoneum were collected by peritoneal lavage. All after immunization, at which time IgMa, anti-Sm, and anti-ssDNA
cells were prepared and washed in complete Hanks' balanced salt production was quantitated by ELISA as described above.
solution (HBSS). Following lysis of red blood cells using 0.15 M
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